Combining Chest X-Ray and Arterial Blood Gas Findings to Predict Need for Mechanical Ventilation in Critically Ill Patients
Launched by ZAGAZIG UNIVERSITY · May 24, 2025
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how well a new machine learning model can predict whether critically ill patients will need mechanical ventilation, which is a machine that helps patients breathe when they can't do it on their own. The researchers are combining information from chest X-rays, which show images of the lungs, with blood tests that measure gas levels in the blood. By using this advanced technology, they hope to make better decisions about patient care in hospitals.
To be part of this study, participants must be adults aged 18 or older who are critically ill and may need mechanical ventilation. There will also be a control group of similar patients who do not need this type of support. Everyone involved will have their chest X-ray and blood test done at the same time to provide the necessary information. The study is currently recruiting participants, and it’s important to note that patients with certain chronic lung diseases or incomplete test results will not be eligible to join. This study aims to improve treatment decisions and ultimately help save lives in critical care settings.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Critically ill adult patients aged 18 years or older.
- • Patients assessed to require mechanical ventilation.
- • Control group: Age- and sex-matched critically ill patients not requiring mechanical ventilation.
- • Availability of both chest X-ray and arterial blood gas (ABG) analysis at the time of evaluation.
- Exclusion Criteria:
- • Patients with missing or incomplete data (e.g., absent chest X-ray or ABG results).
- • Patients with chronic lung diseases unrelated to the current admission (e.g., COPD, pulmonary fibrosis).
- • Pregnant females.
About Zagazig University
Zagazig University, a prominent educational and research institution located in Egypt, plays a pivotal role in advancing medical knowledge and promoting health innovations through its clinical trials. With a commitment to excellence in research, the university leverages its diverse expertise and state-of-the-art facilities to conduct rigorous clinical studies that aim to improve patient care and outcomes. By fostering collaboration among multidisciplinary teams, Zagazig University contributes significantly to the global medical community, ensuring that its clinical trials adhere to the highest ethical standards and regulatory requirements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Zagazig, Al Sharqia, Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported